TORONTO, March 23, 2023 (GLOBE NEWSWIRE) — Vitalhub Corp. (the “Company” or “Vitalhub”) (TSX:VHI) (OTCQX:VHIBF) announced today it has filed its Consolidated Financial Statements and Management’s Discussion and Analysis report for the year ended December 31, 2022, with the Canadian securities authorities. These documents may be viewed under the Company’s profile at www.sedar.com.
“Our record fourth-quarter revenue capped off fiscal 2022 with strong positive momentum across all of our key performance indicators,” said Dan Matlow, Chief Executive Officer of Vitalhub. “The positive organic and accretive inorganic growth contributed to record Q4 and fiscal 2022 revenue, adjusted EBITDA(2), and annual recurring revenue (“ARR”)(1, 2). We have achieved these milestones despite the continued foreign currency headwinds associated with the British pound as contributions from Community Data Solutions (CDS) and Advanced Digital Innovation (ADI) helped drive ARR(1, 2) to over $36 million. We have continued to grow our organic ARR(1, 2) by 3.0% or $925k and achieved record adjusted EBITDA(2) of $2.4 million representing 22% of revenue for Q4 2022. With the addition of Coyote Software Corporation (“Coyote”) after the quarter, the Company’s estimated ARR(1, 2) would be approximately $37 million. We closed the quarter with $17.5 million in cash on hand and combined with the availability of a Bank of Nova Scotia Facility, we currently have $50.5 million at our disposal for operations and to continue progressing our acquisition strategy. We have concluded the fiscal 2022 year with four major acquisitions including Community Data Solutions, Advanced Digital Innovation, Beautiful Information and Hicom and in addition grew our organic ARR(1, 2) by 18.5% or $4.1 million and achieved record adjusted EBITDA(2) of $9.5 million representing 24% of revenue. For fiscal 2022, the Company has consistently focused and executed organic growth initiatives that complemented synergistic M&A activities to deliver strong value to our shareholders. We are excited by the market traction and penetration we have achieved in fiscal 2022 and look forward to continuing efforts to scale our business in 2023.”
Vitalhub Corp’s quarterly investor conference call will take place on Friday, March 24, 2023, at 9:00AM EST.
To register for the call, please visit:
https://us02web.zoom.us/webinar/register/WN_IpaEIPreQQCGNxcPeh6fdQ
Fourth Quarter 2022 Highlights
Annual 2022 Highlights
(1) | The Company defines annual recurring revenue (“ARR”) as the recurring revenue expected based on yearly subscriptions of the renewable software license fees and maintenance services |
(2) | Non-IFRS measure |
Q4 2022 and FY 2022 Results
Three months ended | Year ended | |||||||||
December 31, 2022 | % Revenue | December 31, 2021 | % Revenue | Change | December 31, 2022 | % Revenue | December 31, 2021 | % Revenue | Change | |
$ | $ | % | $ | $ | % | |||||
Revenue | 11,289,606 | 100% | 6,930,290 | 100% | 63% | 39,970,814 | 100% | 24,664,593 | 100% | 62% |
Cost of sales | 1,999,560 | 18% | 1,463,440 | 21% | (37%) | 7,031,819 | 18% | 5,237,210 | 21% | (34%) |
Gross Profit | 9,290,046 | 82% | 5,466,850 | 79% | 70% | 32,938,995 | 82% | 19,427,383 | 79% | 70% |
Operating Expenses | ||||||||||
General and administrative | 2,548,472 | 23% | 1,441,164 | 21% | (77%) | 8,556,468 | 21% | 5,079,379 | 21% | (68%) |
Sales and marketing | 1,126,839 | 10% | 967,630 | 14% | (16%) | 4,275,151 | 11% | 3,614,173 | 15% | (18%) |
Research and development | 3,065,532 | 27% | 1,717,580 | 25% | (78%) | 10,431,212 | 26% | 6,045,799 | 25% | (73%) |
Depreciation | 76,422 | 1% | 45,110 | 1% | (69%) | 250,287 | 1% | 162,424 | 1% | (54%) |
Depreciation of right-of-use assets | 163,222 | 1% | 70,713 | 1% | (131%) | 342,863 | 1% | 272,482 | 1% | (26%) |
Stock based compensation | 267,584 | 2% | 628,789 | 9% | 57% | 1,140,387 | 3% | 1,717,094 | 7% | 34% |
Foreign currency (gain) loss | 93,826 | 1% | (10,383) | (0%) | 1004% | 150,399 | 0% | 137,927 | 1% | (9%) |
Other Income and Expenses | ||||||||||
Amortization of intangible assets | 952,787 | 8% | 622,750 | 9% | (53%) | 3,279,803 | 8% | 2,241,251 | 9% | (46%) |
Business acquisition, restructuring and integration costs | 1,022,171 | 9% | 380,867 | 5% | (168%) | 2,438,904 | 6% | 1,844,212 | 7% | (32%) |
Loss (gain) on change in fair value of contingent consideration | 695,402 | 6% | (128,270) | (2%) | 642% | 695,402 | 2% | (128,270) | (1%) | 642% |
Interest expense and accretion (net of interest income) | 10,288 | 0% | (3,966) | (0%) | 359% | 40,914 | 0% | (29,548) | (0%) | 238% |
Interest expense from lease liabilities | (76,163) | (1%) | 18,195 | 0% | 519% | 29,431 | 0% | 82,432 | 0% | 64% |
(Gain) loss on disposal of property and equipment | 0 | 0% | (561) | (0%) | 100% | 1,057 | 0% | 1,593 | 0% | 34% |
Current and deferred income taxes | (318,005) | (3%) | 323,006 | 5% | 198% | 92,081 | 0% | 333,076 | 1% | 72% |
Net income (loss) | (338,331) | (3%) | (605,773) | (9%) | 44% | 1,214,636 | 3% | (1,946,641) | (8%) | 162% |
EBITDA (Non-IFRS measure) | 470,220 | 4% | 470,034 | 7% | 0% | 5,250,015 | 13% | 1,115,476 | 5% | 371% |
Adjusted EBITDA (Non-IFRS measure) | 2,455,377 | 22% | 1,351,420 | 20% | 82% | 9,524,708 | 24% | 4,548,512 | 18% | 109% |
Annual Recurring Revenue (Non-IFRS measure) | 36,145,150 | 22,106,663 | 64% | 36,145,150 | 22,106,663 | 64% | ||||
Term licences, maintenance and support revenue | 8,736,265 | 77% | 5,290,210 | 76% | 65% | 29,359,361 | 73% | 19,250,266 | 78% | 53% |
Deferred revenue | 15,495,461 | 8,821,331 | ||||||||
Cash balance | 17,452,210 | 16,389,982 |
ABOUT VITALHUB
Software for Health and Human Services providers designed to simplify the user experience and optimize outcomes.
Vitalhub provides technology to Health and Human Services providers including; Hospitals, Regional Health Authorities, Mental Health, Long Term Care, Home Health, Community and Social Services. Vitalhub solutions span the categories of Electronic Health Record (EHR), Case Management, Care Coordination, Patient Flow & Operational Visibility, and DOCit Mobile Apps. The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently, Vitalhub serves 450+ clients across Canada, USA, UK, Australia, Qatar, and Latvia. Vitalhub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Company is publicly traded on the TSX Venture Exchange under the symbol “VHI”.
CAUTIONARY STATEMENT
This press release includes forward-looking statements regarding the Corporation and its business, which may include, but is not limited to, statements with respect to the appointment of a new directors. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including risks regarding the technology industry, failure to obtain regulatory or shareholder approvals, market conditions, economic factors, the equity markets generally and risks associated with growth and competition. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Corporation undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
CONTACT INFORMATION
Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
dan.matlow@Vitalhub.com
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…